IMGT Web resources: IMGT repertoire FR-IMGT and CDR-IMGT lengths: Human TRAV

Print of this table: Folch, G. et al., Exp. Clin. Immunogenet., 17, 205-215 (2000). PMID:11096259
UPDATE: 23/07/2003

TRAV genes are designated according to IMGT gene tables and Locus representations.

Only FUNCTIONAL and ORF V-GENEs are shown.

The proteolytic cleavage site between the leader peptide and the V-REGION is putative and the assignment of amino acid 1 to one or the other region is uncertain.

An asterisk (*) indicates a longer N-terminal end as predicted by the program SIGSEQ2 [Wülfing and Plückthun, Immunology Today, 16, 405-406 (1995)].

TRAV
genes
FR1-IMGT
1 to 26
CDR1-IMGT
27 to 38
FR2-IMGT
39 to 55
CDR2-IMGT
56 to 65
FR3-IMGT
66 to 104
CDR3-IMGT 
(germline V-GENE) 
105 to 115
(25,26,32,34) (5 to 7) (16,17) (3 to 7) (33 to 35) (2 to 5)
TRAV1-1 ,  
TRAV1-2
-1 (aa 7)
6  
5
-7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV2
-1 (aa 7)
6
  3 -7 (aa 71 to 77) +1 (aa 84A) 3
TRAV3   6   7 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 4
TRAV4 -1 (aa 7) 7   4 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 4
TRAV5
-1 (aa 8)
6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV6   6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV7   6   6 -7 (aa 71 to 77) +1 (aa 84A) 3
TRAV8-1 to TRAV8-4
TRAV8-6, 
TRAV8-7
 
6
6
6
 
7
7
7
-7 (aa 71 to 77) +3 (aa 84A,84B,84C)
-7 (aa 71 to 77) +3 (aa 84A,84B,84C)
-7 (aa 71 to 77) +3 (aa 84A,84B,84C)
3
3
5
TRAV9-1, 
TRAV9-2
  6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV10   6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV11   6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 2
TRAV12-1, 
TRAV12-2, 
TRAV12-3
 
6
6
6
 
5
5
5
-1 (aa 67) -7 (aa 71 to 77) +3 (aa 84A,84B,84C)
-7 (aa 71 to 77) +3 (aa 84A,84B,84C)
-7 (aa 71 to 77) +3 (aa 84A,84B,84C)
3
3
3
TRAV13-1, 
TRAV13-2
  6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV14/DV4   7   7 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 4
TRAV16   6   3 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV17   5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV18   6   5 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV19   7   7 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 4
TRAV20   6   6 -7 (aa 71 to 77) +1 (aa 84A) 3
TRAV21   6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV22   5   4 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV23/DV6  +8 aa in 5'* 6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV24   6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 2
TRAV25   5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 2
TRAV26-1, 
TRAV26-2
-1 (aa 7) 7   4 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 4
TRAV27   5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 2
TRAV29/DV5 +6 aa in 5'* 6   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV30  -1 (aa 5) 5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV34   5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV35   5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV36/DV7  
6
-1 (aa 50)
6
-7 (aa 71 to 77) +3 (aa 84A,84B,84C)
3
TRAV38-1, 
TRAV38-2/DV8
  7   7 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 4
TRAV39   5   6 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3
TRAV40 -1 (aa 8) 6   3 -7 (aa 71 to 77) +1 (aa 84A) 3
TRAV41   5   4 -7 (aa 71 to 77) +3 (aa 84A,84B,84C) 3


Created: 08/07/1998
Last updated: Friday, 27-May-2016 21:01:33 CEST
Author: Dominique Scaviner

Software material and data coming from IMGT server may be used for academic research only, provided that it is referred to IMGT®, and cited as "IMGT®, the international ImMunoGeneTics information system® http://www.imgt.org (founder and director: Marie-Paule Lefranc, Montpellier, France)." References to cite: Lefranc, M.-P. et al., Nucleic Acids Res., 27:209-212 (1999); doi: 10.1093/nar/27.1.209 Full text Cover; Ruiz, M. et al., Nucleic Acids Res., 28:219-221 (2000); doi: 10.1093/nar/28.1.219 Full text; Lefranc, M.-P., Nucleic Acids Res., 29:207-209 (2001); doi: 10.1093/nar/29.1.207 Full text; Lefranc, M.-P., Nucleic Acids Res., 31:307-310 (2003); doi: 10.1093/nar/gkg085 Full text; Lefranc, M.-P. et al., In Silico Biol., 5, 0006 (2004) [Epub], 5:45-60 (2005); Lefranc, M.-P. et al., Nucleic Acids Res., 33:D593-597 (2005); doi: 10.1093/nar/gki065 Full text; Lefranc, M.-P. et al., Nucleic Acids Res., 37:D1006-1012 (2009); doi: 10.1093/nar/gkn838 Full text; Lefranc, M.-P. et al., Nucleic Acids Res., 43:D413-422 (2015); doi: 10.1093/nar/gku1056 Full text.
For any other use please contact Marie-Paule Lefranc Marie-Paule.Lefranc@igh.cnrs.fr.

CNRS Université de Montpellier European Commission
IMGT® Founder and Executive Director Emeritus:
Marie-Paule Lefranc Marie-Paule.Lefranc@igh.cnrs.fr
IMGT® Director:
Sofia Kossida Sofia.Kossida@igh.cnrs.fr
Bioinformatics manager:
Véronique Giudicelli Veronique.Giudicelli@igh.cnrs.fr
Computer manager:
Patrice Duroux Patrice.Duroux@igh.cnrs.fr
Webmaster:
Amélie Houles

Citing IMGT | Warranty disclaimer and copyright notice | Privacy policy and advertisement policy

© Copyright 1995-2017 IMGT®, the international ImMunoGeneTics information system®